Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2014

Feb 25, 2014

30597_dirs_2014-02-25_5b4ba78d-d85a-48f3-9768-4dcaf3467383.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2014-02-24

Reporting Person: Megan William J. (SVP, Finance & PFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-24 Stock Option (right to buy) $13.96 A 13000 Acquired 2024-02-24 Common Stock (13000) Direct
2014-02-24 Restricted Stock Units $ A 9000 Acquired Common Stock (9000) Direct
2014-02-24 Restricted Stock Units $ A 45000 Acquired Common Stock (45000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2735 Indirect

Footnotes

F1: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date.

F2: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.

F4: These restricted stock units vest in three equal annual installments beginning on August 26, 2015.